Glutamatergic innervation in bone

Area of Science:

• Neuroscience
• Bone Biology
• Cellular Signaling

Background:

• Nerve fibers regulate bone metabolism, but neuromediators are poorly understood.
• Glutamate (Glu), a CNS neurotransmitter, has been identified in bone marrow nerve fibers.
• Bone cells express the necessary machinery for glutamate signaling.

Purpose of the Study:

• To investigate the role of glutamate as a neuromediator in bone.
• To explore the presence and function of glutamate receptors and transporters in bone cells.
• To determine the impact of glutamatergic signaling on bone remodeling.

Main Methods:

• Demonstration of glutamate signaling machinery (receptors, transporters) in osteoblasts and osteoclasts.
• Electrophysiological studies to confirm functional NMDA receptors (NMDAR) and metabotropic Glu receptors (mGluR) on bone cells.
• Sciatic neurectomy model in rats to assess the effect of reduced glutamatergic innervation on bone loss.

Main Results:

• Osteoblasts and osteoclasts express functional ionotropic and metabotropic glutamate receptors.
• NMDAR activation is linked to osteoclast formation and bone resorption.
• Preliminary data suggest NMDAR involvement in osteoblast proliferation and differentiation.
• Sciatic neurectomy led to decreased glutamatergic innervation and bone loss.

Conclusions:

• Glutamate acts as a neuromediator in bone, directly influencing bone cells and remodeling.
• Glutamatergic signaling plays a significant role in regulating bone metabolism.
• Targeting glutamate pathways presents a potential therapeutic strategy for bone remodeling disorders.